Advanced Inhalation Therapies' Unattributed Round

Advanced Inhalation Therapies raised a round of funding on February 01, 2017.

AIT is a biopharmaceutical company developing novel anti-viral therapeutics based on Nitric Oxide. The Company is applying its therapeutic expertise in NO to address significant medical needs, many of…

Articles about Advanced Inhalation Therapies' Unattributed Round: